Northwest Biotherapeutics Inc (NASDAQ:NWBO)

7.67
Delayed Data
As of Mar 27
 +0.38 / +5.21%
Today’s Change
3.79
Today|||52-Week Range
9.35
+43.36%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues10.0K10.0K772.0K809.0K
 
 
 
 
 
Depreciation And Amortization2.0K10.0K14.0K12.0K
 
 
 
 
 
 
Operating ExpensesGross Income8.0K0.00758.0K797.0K
 
 
 
 
General Expenses15.4M26.8M44.6M56.3M
 
 
 
 
 
Research And Development9.9M13.5M28.9M43.9M
 
 
 
 
 
Total Operating Expenses15.4M26.8M44.6M56.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-15.4M-26.8M-43.8M-55.5M
 
 
 
 
 
Extraordinary Credit54.0K9.5M1.1M1.2M
 
 
 
 
 
Extraordinary Charge-4.7M-7.9M-9.1M-10.6M
 
 
 
 
 
Interest Expense On Debt7.9M7.6M15.5M873.0K
 
 
 
 
 
Other Expenses0.000.000.00-1.0K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-27.4M-32.8M-67.3M-65.8M
 
 
 
 
 
Net Income-27.4M-32.8M-67.3M-65.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS4.2M5.9M11.8M32.9M
 
 
 
 
 
Shares To Calculate EPS Diluted4.2M5.9M11.8M32.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$6.56-$5.60-$5.72-$2.00
 
 
 
 
 
EPS Diluted-$6.56-$5.60-$5.72-$2.00
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account